Ocular biomarkers for cognitive impairment in nonagenarians; a prospective cross-sectional study
Authors:
- Jacoba A. van de KreekeJKJacoba A. van de Kreeke
- Nienke LegdeurNLNienke Legdeur
- Maryam BadissiMBMaryam Badissi
- H. Ton NguyenHNH. Ton Nguyen
- Elles KonijnenbergEKElles Konijnenberg
- Jori TomassenJTJori Tomassen
- Mara Ten KateMKMara Ten Kate
- Anouk Den BraberABAnouk Den Braber
- Andrea B. MaierAMAndrea B. Maier
- H. Stevie TanHTH. Stevie Tan
- Frank D. VerbraakFVFrank D. Verbraak
- Pieter Jelle VisserPVPieter Jelle Visser
Open Access
- 28 April 2020
- journal article
- research article
- Published by Springer Nature in BMC Geriatrics
- Vol. 20 (1) , 1-9
Abstract
Ocular imaging receives much attention as a source of potential biomarkers for dementia. In the present study, we analyze these ocular biomarkers in cognitively impaired and healthy participants in a population aged over 90 years (= nonagenarian), and elucidate the effects of age on these biomarkers. For this prospective cross-sectional study, we included individuals from the EMIF-AD 90+ study, consisting of a cognitively healthy (N = 67) and cognitively impaired group (N = 33), and the EMIF-AD PreclinAD study, consisting of cognitively healthy controls aged ≥60 (N = 198). Participants underwent Optical Coherence Tomography (OCT) and fundus photography of both eyes. OCT was used to asses total and individual inner retinal layer thickness in the macular region (Early Treatment Diabetic Retinopathy Study circles) as well as peripapillary retinal nerve fiber layer thickness, fundus images were analyzed with Singapore I Vessel Assessment to obtain 7 retinal vascular parameters. Values for both eyes were averaged. Differences in ocular biomarkers between the 2 nonagenarian groups were analyzed using linear regression, differences between the individual nonagenarian groups and controls were analyzed using generalized estimating equations. Ocular biomarkers did not differ between the healthy and cognitively impaired nonagenarian groups. 19 out of 22 ocular biomarkers assessed in this study differed between either nonagenarian group and the younger controls. The ocular biomarkers assessed in this study were not associated with cognitive impairment in nonagenarians, making their use as a screening tool for dementing disorders in this group limited. However, ocular biomarkers were significantly associated with chronological age, which were very similar to those ascribed to occur in Alzheimer’s Disease.Keywords
All Related Versions
Funding Information
- EU/EFPIA Innovative Medicines Initiative Joint Undertaking (EMIF grant number 115372)
This publication has 36 references indexed in Scilit:
- Neurovascular Dysfunction Precedes Neural Dysfunction in the Retina of Patients with Type 1 DiabetesInvestigative Ophthalmology & Visual Science, 2013
- The retina as a window to the brain—from eye research to CNS disordersNature Reviews Neurology, 2012
- Quantitative and qualitative retinal microvascular characteristics and blood pressureJournal Of Hypertension, 2011
- Retinal Vascular Tortuosity, Blood Pressure, and Cardiovascular Risk FactorsOphthalmology, 2011
- A New Method to Measure Peripheral Retinal Vascular Caliber over an Extended AreaMicrocirculation, 2010
- Prevalence of dementia after age 90Neurology, 2008
- Netherlands Twin Register: From Twins to Twin FamiliesTwin Research and Human Genetics, 2006
- Mild cognitive impairment as a diagnostic entityJournal of Internal Medicine, 2004
- Relationships between Age, Blood Pressure, and Retinal Vessel Diameters in an Older PopulationInvestigative Ophthalmology & Visual Science, 2003
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984